PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19
Revenue
244.30 320.06 198.11 54.76
Revenue Growth
(58.62%) 31.01% (38.10%) (72.36%)
Cost of Revenue
4.07 30.54 48.46 53.62
Gross Profit
240.24 289.52 149.65 1.14
R&D Expenses
3.82 7.38 2.96 7.31
SG&A Expenses
40.33 63.32 62.56 54.08
Operating Income
129.40 193.78 (50.59) (99.81)
Non-operating Income/Expense
(20.03) (9.25) (5.33) 26.07
Non-operating Interest Expenses
18.27 20.22 12.16 11.40
EBT
109.37 184.53 (55.92) (73.74)
Income Tax Provision
45.71 73.83 12.94 (3.05)
Income after Tax
63.66 110.70 (68.86) (70.69)
Dividends (Preferred)
— 0.00 — —
Non-Controlling Interest
0.05 (0.05) — (0.28)
Net Income Common
63.61 110.75 (68.86) (70.41)
EPS (Basic)
0.39 0.71 (0.47) (0.59)
EPS (Diluted)
0.39 0.71 (0.47) (0.59)
Shares (Basic, Weighted)
163.81 155.39 145.67 118.63
Shares (Diluted, Weighted)
164.19 156.26 145.67 118.63
Gross Margin
98.34% 90.46% 75.54% 2.08%
EBIT Margin
52.97% 60.54% (25.54%) (182.29%)
EBT margin
44.77% 57.65% (28.23%) (134.67%)
Net Profit Margin
26.04% 34.60% (34.76%) (128.59%)
Free Cash Flow Margin
46.98% 45.80% 20.20% 90.15%
EBITDA
151.46 231.87 (23.46) (82.40)
EBIT
129.40 193.78 (50.59) (99.81)
Income from Continuous Operations
63.66 110.70 (68.86) (70.69)
Consolidated Net Income/Loss
63.66 110.70 (68.86) (70.69)
EPS (Basic, from Continuous Ops)
0.39 0.71 (0.47) (0.60)
EPS (Basic, Consolidated)
0.39 0.71 (0.47) (0.60)
EPS (Diluted, from Cont. Ops)
0.39 0.71 (0.47) (0.60)
Shares (Diluted, Average)
164.19 156.26 145.67 118.63
EPS (Diluted, Consolidated)
0.39 0.71 (0.47) (0.60)
EBITDA Margin
62.00% 72.45% (11.84%) (150.49%)
Operating Cash Flow Margin
41.64% 12.69% (6.78%) (59.25%)

Fold the line items

In millions of $ except per-share values · columns are period end dates